Cardiovascular disease - DiabetesontheNet

A meta-analysis provides more evidence to support aspirin for primary prevention of cardiovascular disease

Fundamentals in diabetes. Part 1: An introduction to vascular complications

Quality, Innovation, Productivity and Prevention (QIPP) – what does it mean for diabetes care?

Blood pressure control in people with type 2 diabetes: How low is too low?

Physical inactivity: A major independent risk factor for CHD in south Asian people

ACCORD: More data, more debate

ACCORD 5-year follow-up results: Primum non nocere

Patient knowledge of risk factors 18 months after a nurse-led vascular intervention

Reassuring data on safety of exenatide in reducing the incidence of CVD events

Multifactorial CV intervention in people with type 2 diabetes: Striking a balance

Metformin and heart failure in type 2 diabetes

Metformin for secondary prevention of CVD?

If sulphonylureas are more harmful than rosiglitazone, why has the latter been withdrawn, and the former has not?

An audit of the “deadly trio” in GP practices in Birmingham

Erectile dysfunction as a marker of CVD

Neuropathy – a predictor of cardiovascular disease?

ACCORD treatment resulted in microvascular benefit even in people with long-standing type 2 diabetes

Strong evidence for higher levels of fitness reducing the risk of diabetes